Viewing Study NCT06984718


Ignite Creation Date: 2025-12-25 @ 4:35 AM
Ignite Modification Date: 2025-12-26 @ 3:37 AM
Study NCT ID: NCT06984718
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-05-22
First Post: 2025-05-15
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCC
Sponsor: Akeso
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module